Search Results - "Urrunaga, D."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3

    SARC-F and SARC-CalF Scores as Mortality Risk Factors in Older Men with Cancer: A Longitudinal Study from Peru by Ururi-Cupi, K., Oliva-Zapata, F., Salazar-Talla, L., Cuba-Ruiz, S., Urrunaga-Pastor, Diego, Runzer-Colmenares, Fernando M., Parodi, J. F.

    Published in The Journal of nutrition, health & aging (01-09-2022)
    “…Objectives We aimed to evaluate the role of SARC-F and SARC-CalF scores as risk factors for mortality in adults over 60 years of age with cancer of the Centro…”
    Get full text
    Journal Article
  4. 4

    Frailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peru by Runzer-Colmenares, Fernando M., Urrunaga-Pastor, D., Roca-Moscoso, M. A., De Noriega, J., Rosas-Carrasco, O., Parodi, J. F.

    Published in The Journal of nutrition, health & aging (01-09-2020)
    “…Background Multiple markers are used to assess frailty and vulnerability, conditions associated with the development of chemotherapy toxicity (CTT). However,…”
    Get full text
    Journal Article
  5. 5

    Frailty and Vulnerability as Predictors of Chemotherapy Toxicity in Older Adults: A Longitudinal Study in Peru by Runzer-Colmenares, F M, Urrunaga-Pastor, D, Roca-Moscoso, M A, De Noriega, J, Rosas-Carrasco, O, Parodi, J F

    “…Multiple markers are used to assess frailty and vulnerability, conditions associated with the development of chemotherapy toxicity (CTT). However, there is…”
    Get full text
    Journal Article
  6. 6

    Abstract P3-08-18: Clinicopathological characteristics associated with intermediate and high-risk ODx RS by Ruiz, R, Morante, Z, Namuche, F, Urrunaga, D, Leon, M, Ziegler, G, Aguilar, A, Chavez Mac Gregor, M, Gomez, H

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Background: The gene expression profiling assay OncotypeDx (ODx) prognosticates the risk of estrogen receptor positive (ER+) breast cancer (BC) recurrence and…”
    Get full text
    Journal Article
  7. 7

    Abstract P3-08-16: Age's importance in early breast cancer: Oncotype Dx results in patients ≤40 years by Ruiz, R, Namuche, F, Morante, Z, Aguilar, A, Urrunaga, D, Ziegler, G, Chavez Mac Gregor, M, Leon, M, Gomez, H

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Background The 21-gene recurrence score (RS) predicts the benefit of adjuvant chemotherapy (CT) in ER-positive HER2-negative breast cancer (BC) and has been…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Abstract P3-08-17: Evaluation of Oncotype DX testing and subsequent treatment choices in the Latin American setting by Ruiz, R, Morante, Z, Namuche, F, Urrunaga, D, Aguilar, A, Schwarz, J, Leon, M, Ziegler, G, Chavez Mac Gregor, M, Gomez, H

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Background: The gene expression profiling assay OncotypeDx (ODx) prognosticates the risk of estrogen receptor positive (ER+) breast cancer (BC) recurrence and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    COVID-19 Mortality in Peruvian Older Adults: A Chronicle of a Health Crisis Foretold? by Aguirre-Amaya, K. L, Palomares-Custodio, M, Quispe-Vicuña, C, Abanto-Urbano, S, Urrunaga-Pastor, Diego

    Published in The Journal of frailty & aging (01-02-2021)
    “…Physiological changes associated with aging, a decrease in immune system response, the presence of disability, chronic diseases and polypharmacy are…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15